SUVEN LIFE SCIENCES LTD.

Company Profile

SUVEN LIFE SCIENCES LTD. had its IPO on under the ticker symbol SUVEN.

The company operates in the Other sector and Other industry. SUVEN LIFE SCIENCES LTD. has a staff strength of 0 employees.

Stock update

Shares of SUVEN LIFE SCIENCES LTD. opened at ₹74.19 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹67.49 - ₹74.19, and closed at ₹72.55.

This is a +3.94% increase from the previous day's closing price.

A total volume of 223,727 shares were traded at the close of the day’s session.

In the last one week, shares of SUVEN LIFE SCIENCES LTD. have increased by +10.58%.

SUVEN LIFE SCIENCES LTD.'s Key Ratios

SUVEN LIFE SCIENCES LTD. has a market cap of ₹7.30 billion, indicating a price to book ratio of 24.2315 and a price to sales ratio of 56.0311.

In the last 12-months SUVEN LIFE SCIENCES LTD.’s revenue was ₹221.31 million with a gross profit of ₹146.83 million and an EBITDA of ₹-846648000. The EBITDA ratio measures SUVEN LIFE SCIENCES LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SUVEN LIFE SCIENCES LTD.’s operating margin was -398.05% while its return on assets stood at -7.98% with a return of equity of -14.33%.

In Q4, SUVEN LIFE SCIENCES LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a negative 96.7%.

SUVEN LIFE SCIENCES LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹-5.85 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SUVEN LIFE SCIENCES LTD.’s profitability.

SUVEN LIFE SCIENCES LTD. stock is trading at a EV to sales ratio of 81.9189 and a EV to EBITDA ratio of -15.4218. Its price to sales ratio in the trailing 12-months stood at 56.0311.

SUVEN LIFE SCIENCES LTD. stock pays annual dividends of ₹2.5 per share, indicating a yield of 4.36% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹1.21 billion

Total Liabilities

₹605.69 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

SUVEN LIFE SCIENCES LTD. ended 2024 with ₹1.21 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.21 billion while shareholder equity stood at ₹564.72 million.

SUVEN LIFE SCIENCES LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹605.69 million in other current liabilities, 145382000.00 in common stock, ₹419.34 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹167.90 million and cash and short-term investments were ₹621.79 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.

SUVEN LIFE SCIENCES LTD.’s total current assets stands at ₹802.53 million while long-term investments were ₹0 and short-term investments were ₹451.50 million. Its net receivables were ₹13.39 million compared to accounts payable of ₹36.61 million and inventory worth ₹224000.00.

In 2024, SUVEN LIFE SCIENCES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, SUVEN LIFE SCIENCES LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹72.55

52-Week High

₹80.5368

52-Week Low

₹45.01

Analyst Target Price

₹

SUVEN LIFE SCIENCES LTD. stock is currently trading at ₹72.55 per share. It touched a 52-week high of ₹80.5368 and a 52-week low of ₹80.5368. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹64.56 and 200-day moving average was ₹60.7 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6352.9% of the company’s stock are held by insiders while 102.4% are held by institutions.